148P First-line (1L) treatment (tx) patterns and criteria used to determine platinum eligibility (PE) in platinum-eligible and -ineligible (PI) patients (pts) with metastatic urothelial cancer (mUC) in South Korea (KR) and Taiwan (TW)
| Autor: | Milloy, N., Berry, M., Montgomery, R., Kluth, C., Bleasdale, C., Kirker, M., Kearney, M., Mohamed, W.E.M., Costa, N., Chang, J. |
|---|---|
| Zdroj: | In Annals of Oncology November 2022 33 Supplement 9:S1490-S1490 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|